|
Market Closed -
Saudi Arabian S.E.
08:20:00 2026-04-29 EDT
|
5-day change | 1st Jan Change | ||
| 18.74 SAR | -1.32% |
|
-.--% | -22.91% |
| 09-20 | Nama Chemicals Company(SASE:2210) dropped from S&P Global BMI Index | CI |
| 08-03 | Nama Chemicals Seeks Compensation from Al-Rawaq Consortium via Arbitration | MT |
Company Valuation: Nama Chemicals Company
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 555.5 | 777.7 | 753.2 | 776.2 | 755 | 656.2 |
| Change | - | 39.99% | -3.15% | 3.05% | -2.73% | -13.08% |
| Enterprise Value (EV) 1 | 1,323 | 1,525 | 1,270 | 1,256 | 1,262 | 1,214 |
| Change | - | 15.27% | -16.68% | -1.16% | 0.52% | -3.8% |
| P/E | 472x | -17.2x | 27.8x | 21x | -4.95x | 56x |
| PBR | 1.8x | 2.71x | 2.28x | 2.01x | 3.23x | 2.69x |
| PEG | - | 0x | -0x | 0.6x | 0x | -1x |
| Capitalization / Revenue | 1.06x | 1.77x | 1.36x | 1.34x | 1.7x | 1.73x |
| EV / Revenue | 2.51x | 3.47x | 2.29x | 2.18x | 2.83x | 3.19x |
| EV / EBITDA | 23.4x | 93.3x | 16.9x | 11.9x | -19.3x | -15.3x |
| EV / EBIT | 161x | -38.7x | 82.2x | 28.8x | -10.3x | -8.58x |
| EV / FCF | 15.2x | 36.2x | 21x | 68.8x | 83.5x | -53.6x |
| FCF Yield | 6.6% | 2.76% | 4.77% | 1.45% | 1.2% | -1.87% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.05 | -1.937 | 1.162 | 1.574 | -6.481 | 0.498 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 525.9 | 439.2 | 554.3 | 577.2 | 445.2 | 380.3 |
| EBITDA 1 | 56.45 | 16.34 | 75.04 | 105.5 | -65.28 | -79.41 |
| EBIT 1 | 8.223 | -39.43 | 15.45 | 43.65 | -122.8 | -141.5 |
| Net income 1 | 1.176 | -45.25 | 27.33 | 37.02 | -152.4 | 11.72 |
| Net Debt 1 | 767.1 | 747 | 517.2 | 479.4 | 507.2 | 558 |
| Reference price 2 | 23.62 | 33.30 | 32.25 | 33.00 | 32.10 | 27.90 |
| Nbr of stocks (in thousands) | 23,520 | 23,355 | 23,355 | 23,520 | 23,520 | 23,520 |
| Announcement Date | 3/30/20 | 3/31/21 | 3/20/22 | 3/21/23 | 3/28/24 | 4/13/25 |
1SAR in Million2SAR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 117M | ||
| 30.59x | 6.97x | 17.89x | 1.27% | 232B | ||
| 28.74x | 4.42x | 14.26x | 2.05% | 126B | ||
| 20.16x | 7.18x | 31.88x | 3.67% | 75.92B | ||
| 29.64x | 3.58x | 18.53x | 0.98% | 79.28B | ||
| 92.56x | 6.79x | 15.81x | 2.32% | 69.42B | ||
| 88.37x | 1.31x | 9.14x | 5.88% | 37.63B | ||
| 10.96x | 1.08x | 5.87x | 2.83% | 33.17B | ||
| 16.3x | 1.88x | 10.91x | 2.43% | 26.51B | ||
| 17.16x | 0.86x | 5.98x | 4.15% | 24.43B | ||
| Average | 37.17x | 3.78x | 14.47x | 2.84% | 70.45B | |
| Weighted average by Cap. | 36.30x | 5.15x | 16.91x | 2.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2210 Stock
- Valuation Nama Chemicals Company
Select your edition
All financial news and data tailored to specific country editions
















